UCBJF - UCB launches newly approved psoriasis drug Bimzelx in US November, 14 2023 02:27 PM Ucb Sa Npv 2023-11-14 14:27:51 ET More on UCB SA FDA approves UCB's Bimzelx for plaque psoriasis Historical earnings data for UCB SA Dividend scorecard for UCB SA Financial information for UCB SA For further details see: UCB launches newly approved psoriasis drug Bimzelx in US